Back to STATE STREET CORP STATE STREET CORP

CRSPCRSP
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in CRISPR THERAPEUTICS AG

STATE STREET CORP holds 4.3M shares of CRSP (CRISPR THERAPEUTICS AG), worth $235.7M as of 2026-Q2. The position was increased (+8.5% shares). CRSP represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$235.7M

Current Shares

4.3M

Total Value Change

+$125.9M

Total Shares Change

+2.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.3M
+8.5%
$235.7M0.0%$54.54
33
2026-Q1
Increased
4M
+6.1%
$189.4M0.0%$58.06
32
2025-Q4
Decreased
3.8M
-6.3%
$196.8M0.0%$53.19
0
2025-Q3
Increased
4M
+22.5%
$259.7M0.0%$63.77
37
2025-Q2
Increased
3.3M
+35.6%
$159.1M0.0%$47.49
39
2025-Q1
Decreased
2.4M
-3.2%
$82.1M0.0%$36.99
0
2024-Q4
Decreased
2.5M
-16.8%
$98.1M0.0%$38.65
0
2024-Q3
Increased
3M
+25.0%
$140.6M0.0%$47.32
37
2024-Q2
Increased
2.4M
+60.1%
$129.3M0.0%$54.01
43
2024-Q1
Decreased
1.5M
-14.7%
$101.9M0.0%$68.16
0
2023-Q4
New
1.8M
-
$109.8M0.0%$62.60
42

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used